Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Frontiers in Aging Neuroscience 14 (202): 892754.
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2022
- Urheber
-
Ouanes, Sami
Clark, Christopher
Richiardi, Jonas
Maréchal, Bénédicte
Lewczuk, Piotr
Kornhuber, Johannes
Kirschbaum, Clemens
Popp, Julius
- DOI
-
10.3389/fnagi.2022.892754
- URN
-
urn:nbn:de:bvb:29-opus4-198741
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:43 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ouanes, Sami
- Clark, Christopher
- Richiardi, Jonas
- Maréchal, Bénédicte
- Lewczuk, Piotr
- Kornhuber, Johannes
- Kirschbaum, Clemens
- Popp, Julius
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2022
Ähnliche Objekte (12)
Cerebrospinal Fluid of Patients With Alzheimer’s Disease Contains Increased Percentages of Synaptophysin-Bearing Microvesicles
Alzheimer’s Disease—Biochemical and Psychological Background for Diagnosis and Treatment
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Multiple Discriminant Analysis of SPECT Data for Alzheimer’s Disease, Frontotemporal Dementia and Asymptomatic Controls
Digit Ratio (2D:4D) Is Not Associated with Alzheimer’s Disease in the Elderly
Imbalance of Circulating Th17 and Regulatory T Cells in Alzheimer’s Disease: A Case Control Study
Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls
Biomarkers for the Diagnosis of Alzheimer’s Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Metabolite profiling of Alzheimer's disease cerebrospinal fluid
Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer’s disease
Pulsed Arterial Spin Labeling and Segmented Brain Volumetry in the Diagnostic Evaluation of Frontotemporal Dementia, Alzheimer’s Disease and Mild Cognitive Impairment
Cerebrospinal Fluid of Patients With Alzheimer’s Disease Contains Increased Percentages of Synaptophysin-Bearing Microvesicles
Alzheimer’s Disease—Biochemical and Psychological Background for Diagnosis and Treatment
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Multiple Discriminant Analysis of SPECT Data for Alzheimer’s Disease, Frontotemporal Dementia and Asymptomatic Controls
Digit Ratio (2D:4D) Is Not Associated with Alzheimer’s Disease in the Elderly
Imbalance of Circulating Th17 and Regulatory T Cells in Alzheimer’s Disease: A Case Control Study
Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls
Biomarkers for the Diagnosis of Alzheimer’s Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Metabolite profiling of Alzheimer's disease cerebrospinal fluid
Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer’s disease
Pulsed Arterial Spin Labeling and Segmented Brain Volumetry in the Diagnostic Evaluation of Frontotemporal Dementia, Alzheimer’s Disease and Mild Cognitive Impairment
Cerebrospinal Fluid of Patients With Alzheimer’s Disease Contains Increased Percentages of Synaptophysin-Bearing Microvesicles
Alzheimer’s Disease—Biochemical and Psychological Background for Diagnosis and Treatment
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Multiple Discriminant Analysis of SPECT Data for Alzheimer’s Disease, Frontotemporal Dementia and Asymptomatic Controls
Digit Ratio (2D:4D) Is Not Associated with Alzheimer’s Disease in the Elderly
Imbalance of Circulating Th17 and Regulatory T Cells in Alzheimer’s Disease: A Case Control Study
Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls
Biomarkers for the Diagnosis of Alzheimer’s Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Metabolite profiling of Alzheimer's disease cerebrospinal fluid
Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer’s disease